Liquid crystal nanoparticle formulation as an oral drug delivery system for liver-specific distribution

about

Liquid crystal nanoparticle formulation as an oral drug delivery system for liver-specific distribution

Item

http://www.wikidata.org/entity/Q36659315

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Liquid crystal nanoparticle fo ...... or liver-specific distribution

@ast

Liquid crystal nanoparticle fo ...... or liver-specific distribution

@en

type

Item

label

Liquid crystal nanoparticle fo ...... or liver-specific distribution

@ast

Liquid crystal nanoparticle fo ...... or liver-specific distribution

@en

prefLabel

Liquid crystal nanoparticle fo ...... or liver-specific distribution

@ast

Liquid crystal nanoparticle fo ...... or liver-specific distribution

@en

P1476

Liquid crystal nanoparticle fo ...... or liver-specific distribution

@en

P2093

B Moon Kim

http://www.w3.org/2001/XMLSchema#string

Dong Ryeol Lee

http://www.w3.org/2001/XMLSchema#string

Il Hak Bae

http://www.w3.org/2001/XMLSchema#string

Ji Su Park

http://www.w3.org/2001/XMLSchema#string

P2860

PEGylation, successful approach to drug delivery

The future of peptide-based drugs

Novel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9

Recent advances with liposomes as pharmaceutical carriers

Potent Hepatitis C Virus NS5A Inhibitors Containing a Benzidine Core.

Cubic and hexagonal liquid crystals as drug delivery systems.

Self-assembling biomaterials: liquid crystal phases of cholesteryl oligo(L-lactic acid) and their interactions with cells.

Characterisation and Skin Distribution of Lecithin-Based Coenzyme Q10-Loaded Lipid Nanocapsules

Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption.

Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules.

P304

853-871

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S97000

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yan Lee

P577

2016-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27042053

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery

nanoparticle

P932

4780723

http://www.w3.org/2001/XMLSchema#string